These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 34164881)

  • 1. Safety and efficacy of left atrial appendage closure using an epicardial suture snaring device: Systematic review and current status.
    Sabzwari SRA; Mehta NA; Garg L; Racharla L; Kurtz E; Afzal MR; Turagam MK; Lakkireddy D
    J Cardiovasc Electrophysiol; 2021 Aug; 32(8):2189-2198. PubMed ID: 34164881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicenter study on acute and long-term safety and efficacy of percutaneous left atrial appendage closure using an epicardial suture snaring device.
    Miller MA; Gangireddy SR; Doshi SK; Aryana A; Koruth JS; Sennhauser S; d'Avila A; Dukkipati SR; Neuzil P; Reddy VY
    Heart Rhythm; 2014 Nov; 11(11):1853-9. PubMed ID: 25068574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short and long-term outcomes of percutaneous left atrial appendage suture ligation: Results from a US multicenter evaluation.
    Lakkireddy D; Afzal MR; Lee RJ; Nagaraj H; Tschopp D; Gidney B; Ellis C; Altman E; Lee B; Kar S; Bhadwar N; Sanchez M; Gadiyaram V; Evonich R; Rasekh A; Cheng J; Cuoco F; Chandhok S; Gunda S; Reddy M; Atkins D; Bommana S; Cuculich P; Gibson D; Nath J; Ferrell R; Matthew E; Wilber D
    Heart Rhythm; 2016 May; 13(5):1030-1036. PubMed ID: 26872554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early results with the LARIAT device for left atrial appendage exclusion in patients with atrial fibrillation at high risk for stroke and anticoagulation.
    Stone D; Byrne T; Pershad A
    Catheter Cardiovasc Interv; 2015 Jul; 86(1):121-7. PubMed ID: 23765504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous left atrial appendage suture ligation using the LARIAT device in patients with atrial fibrillation: initial clinical experience.
    Bartus K; Han FT; Bednarek J; Myc J; Kapelak B; Sadowski J; Lelakowski J; Bartus S; Yakubov SJ; Lee RJ
    J Am Coll Cardiol; 2013 Jul; 62(2):108-118. PubMed ID: 23062528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Left atrial appendage ligation with the next generation LARIAT(+) suture delivery device: Early clinical experience.
    Bartus K; Gafoor S; Tschopp D; Foran JP; Tilz R; Wong T; Lakkireddy D; Sievert H; Lee RJ
    Int J Cardiol; 2016 Jul; 215():244-7. PubMed ID: 27128539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early safety and efficacy of percutaneous left atrial appendage suture ligation: results from the U.S. transcatheter LAA ligation consortium.
    Price MJ; Gibson DN; Yakubov SJ; Schultz JC; Di Biase L; Natale A; Burkhardt JD; Pershad A; Byrne TJ; Gidney B; Aragon JR; Goldstein J; Moulton K; Patel T; Knight B; Lin AC; Valderrábano M
    J Am Coll Cardiol; 2014 Aug; 64(6):565-72. PubMed ID: 25104525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial experience with a novel percutaneous left atrial appendage exclusion device in patients with atrial fibrillation, increased stroke risk, and contraindications to anticoagulation.
    Massumi A; Chelu MG; Nazeri A; May SA; Afshar-Kharaghan H; Saeed M; Razavi M; Rasekh A
    Am J Cardiol; 2013 Mar; 111(6):869-73. PubMed ID: 23312129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term clinical outcomes from real-world experience of left atrial appendage exclusion with LARIAT device.
    Parikh V; Bartus K; Litwinowicz R; Turagam MK; Sadowski J; Kapelak B; Bartus M; Podolec J; Brzezinski M; Musat D; Rasekh A; Mittal S; Cheng J; Badhwar N; Lee R; Lakkireddy D
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2849-2857. PubMed ID: 31596044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of multimodality imaging in percutaneous left atrial appendage suture ligation with the LARIAT device.
    Laura DM; Chinitz LA; Aizer A; Holmes DS; Benenstein R; Freedberg RS; Kim EE; Saric M
    J Am Soc Echocardiogr; 2014 Jul; 27(7):699-708. PubMed ID: 24874974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence and causes of in-hospital outcomes and 30-day readmissions after percutaneous left atrial appendage closure: A US nationwide retrospective cohort study using claims data.
    Vuddanda VLK; Turagam MK; Umale NA; Shah Z; Lakkireddy DR; Bartus K; McCausland FR; Velagapudi P; Mansour M; Heist EK
    Heart Rhythm; 2020 Mar; 17(3):374-382. PubMed ID: 31539630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left Atrial Appendage Closure for Stroke Prevention: Devices, Techniques, and Efficacy.
    Iskandar S; Vacek J; Lavu M; Lakkireddy D
    Cardiol Clin; 2016 May; 34(2):329-51. PubMed ID: 27150181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and long-term outcomes of epicardial left atrial appendage ligation with the second-generation LARIAT device: a high-volume electrophysiology center experience.
    Fink T; Schlüter M; Tilz RR; Heeger CH; Lemes C; Maurer T; Reissmann B; Rottner L; Santoro F; Mathew S; Rillig A; Ouyang F; Kuck KH; Metzner A
    Clin Res Cardiol; 2018 Dec; 107(12):1139-1147. PubMed ID: 29881879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early and Middle-Term Results and Anticoagulation Strategy after Left Atrial Appendage Exclusion Using an Epicardial Clip Device.
    Yoshimoto A; Suematsu Y; Kurahashi K; Kaneko H; Arima D; Nishi S
    Ann Thorac Cardiovasc Surg; 2021 Jun; 27(3):185-190. PubMed ID: 33208590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Unconventional combination of left atrial appendage device occlusion in patients with atrial fibrillation who needed concomitant catheter interventions for underlying structural heart disease.
    Raghuram P; Pavithran S; Sivakumar K
    Indian Heart J; 2020; 72(5):369-375. PubMed ID: 33189196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Initial experience with the WATCHMAN™ left atrial appendage system for stroke prevention in atrial fibrillation: A single-centre registry.
    Bonnet G; Salaun E; Pankert M; Cuisset T; Bonnet JL
    Arch Cardiovasc Dis; 2016 Dec; 109(12):689-695. PubMed ID: 27594651
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of thromboembolic events after percutaneous left atrial appendage ligation in patients with atrial fibrillation: Long-term results of a multicenter study.
    Mohanty S; Gianni C; Trivedi C; Gadiyaram V; Della Rocca DG; MacDonald B; Horton R; Al-Ahmad A; Gibson DN; Price M; Krumerman AK; Palma EC; Di Biase L; Lakkireddy D; Natale A
    Heart Rhythm; 2020 Feb; 17(2):175-181. PubMed ID: 31400519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left Atrial Appendage Remodeling After Lariat Left Atrial Appendage Ligation.
    Kreidieh B; Rojas F; Schurmann P; Dave AS; Kashani A; Rodríguez-Mañero M; Valderrábano M
    Circ Arrhythm Electrophysiol; 2015 Dec; 8(6):1351-8. PubMed ID: 26486856
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-Term Safety and Efficacy in Continued Access Left Atrial Appendage Closure Registries.
    Holmes DR; Reddy VY; Gordon NT; Delurgio D; Doshi SK; Desai AJ; Stone JE; Kar S
    J Am Coll Cardiol; 2019 Dec; 74(23):2878-2889. PubMed ID: 31806131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. First experience with the Watchman FLX occluder for percutaneous left atrial appendage closure.
    Seeger J; Birkemeyer R; Rottbauer W; Wöhrle J
    Cardiovasc Revasc Med; 2017; 18(7):512-516. PubMed ID: 28495117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.